High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3-4 : Results of a 12-week double-blind, randomized, controlled study
Background Calcidiol insufficiency may accelerate the development of secondary hyperparathyroidism (SHPT). We tested the effect of a substantial increase in calcidiol on mineral metabolism in patients with chronic kidney disease (CKD). Methods Ninety-five patients with CKD Stages 3-4, parathyroid hormone (PTH) above 6.8 pmol/L and calcidiol below 75 nmol/L were randomized to receive either choleca
